Less Waste. More Care.
Glucotrack’s implantable CBGM reduces the endless cycle of disposable CGM waste
Less Waste. More Care.
Glucotrack’s implantable CBGM reduces the endless cycle of disposable CGM waste
Glucotrack is making news
Discover how we’re progressing toward the commercialization of our CBGM technology.
Advancing research in continuous glucose monitoring
Glucotrack is a medical technology company investigating a novel approach to continuous blood glucose monitoring. Our current focus is on developing a fully implantable system intended to improve glycemic monitoring for people living with diabetes.
About UsRethinking glucose monitoring
Our early stage research is focused on a system that aims to reduce the burden of daily management by eliminating external wearables and measuring glucose directly from the blood.
CBGM TechnologyPioneering a breakthrough in glucose monitoring
Glucotrack is a medical technology innovator, developing and commercializing groundbreaking technologies designed to improve accuracy, convenience, and independence for people living with diabetes.
About Us
Innovative technology that’s rewriting the rules
Our long-term implantable Continuous Blood Glucose Monitoring (CBGM) technology is gearing up to be a game-changer, unobtrusively integrating into everyday life.
CBGM TechnologyGlucotrack’s implantable CBGM is an investigational device and has not been approved by the FDA. Safety and effectiveness have not been established.
Information for investors
Access the latest financial news, presentations, and events.
Investor Resources